Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 22, 2023
Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC
Dongchen Sun, Jiaqing Liu, Huaqiang Zhou, et al.
Cell Reports
|
March 14, 2024
Housekeeping U1 snRNA facilitates antiviral innate immunity by promoting TRIM25-mediated RIG-I activation
Fan Zhang, Siying Liu, Zigang Qiao, et al.
Plos Pathogens
|
June 25, 2015
Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice
Junjie Zhang, Lining Zhu, Xiaolu Lu, et al.
Med (New York, N.Y.)
|
October 12, 2024
A tumor cornification and immune-infiltration-based scheme for anti-PD-1 plus chemotherapy response in advanced squamous cell lung carcinoma
Minlin Jiang, Jiya Sun, Congli Hu, et al.
Cell Stem Cell
|
October 8, 2019
Single-Cell Transcriptome Analysis of Uniparental Embryos Reveals Parent-of-Origin Effects on Human Preimplantation Development
Lizhi Leng, Jiya Sun, Jinrong Huang, et al.
BMJ Oncology
|
January 31, 2025
Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer
Zhenhua Liu, Ke Ma, Qingzhu Jia, et al.
Nature Communications
|
November 5, 2021
Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity
Yunqian Qiao, Yangmin Qiu, Jie Ding, et al.
American Journal of Cancer Research
|
October 18, 2021
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors
Haiping Jiang, Ning Li, Huan Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
June 24, 2021
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
Haiqing Ni, Lei Cao, Zhihai Wu, et al.
Nature Cancer
|
August 7, 2023
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25<sup>+</sup>CD8<sup>+</sup> T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 22, 2023
Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC
Dongchen Sun, Jiaqing Liu, Huaqiang Zhou, et al.
Cell Reports
|
March 14, 2024
Housekeeping U1 snRNA facilitates antiviral innate immunity by promoting TRIM25-mediated RIG-I activation
Fan Zhang, Siying Liu, Zigang Qiao, et al.
Plos Pathogens
|
June 25, 2015
Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice
Junjie Zhang, Lining Zhu, Xiaolu Lu, et al.
Med (New York, N.Y.)
|
October 12, 2024
A tumor cornification and immune-infiltration-based scheme for anti-PD-1 plus chemotherapy response in advanced squamous cell lung carcinoma
Minlin Jiang, Jiya Sun, Congli Hu, et al.
Cell Stem Cell
|
October 8, 2019
Single-Cell Transcriptome Analysis of Uniparental Embryos Reveals Parent-of-Origin Effects on Human Preimplantation Development
Lizhi Leng, Jiya Sun, Jinrong Huang, et al.
BMJ Oncology
|
January 31, 2025
Baseline tumour vessel perfusion as a non-invasive predictive biomarker for immune checkpoint therapy in non-small-cell lung cancer
Zhenhua Liu, Ke Ma, Qingzhu Jia, et al.
Nature Communications
|
November 5, 2021
Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity
Yunqian Qiao, Yangmin Qiu, Jie Ding, et al.
American Journal of Cancer Research
|
October 18, 2021
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors
Haiping Jiang, Ning Li, Huan Wang, et al.
Cancer Immunology, Immunotherapy : CII
|
June 24, 2021
Combined strategies for effective cancer immunotherapy with a novel anti-CD47 monoclonal antibody
Haiqing Ni, Lei Cao, Zhihai Wu, et al.
Nature Cancer
|
August 7, 2023
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25<sup>+</sup>CD8<sup>+</sup> T cells
Weiwei Wu, Tiongsun Chia, Jia Lu, et al.
Page
of 4